WO1997030718A1 - Antimicrobial composition - Google Patents

Antimicrobial composition Download PDF

Info

Publication number
WO1997030718A1
WO1997030718A1 PCT/AU1997/000092 AU9700092W WO9730718A1 WO 1997030718 A1 WO1997030718 A1 WO 1997030718A1 AU 9700092 W AU9700092 W AU 9700092W WO 9730718 A1 WO9730718 A1 WO 9730718A1
Authority
WO
WIPO (PCT)
Prior art keywords
antimicrobial composition
steam
foliage
melaleuca
sealed vessel
Prior art date
Application number
PCT/AU1997/000092
Other languages
French (fr)
Inventor
Thomas Keith Stacey
Original Assignee
Thomas Keith Stacey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas Keith Stacey filed Critical Thomas Keith Stacey
Priority to AU17135/97A priority Critical patent/AU1713597A/en
Publication of WO1997030718A1 publication Critical patent/WO1997030718A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08Magnoliopsida [dicotyledons]
    • A01N65/28Myrtaceae [Myrtle family], e.g. teatree or clove
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/61Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Definitions

  • antimicrobial composition may have many other uses and that the above examples should be read as only some examples of uses for the composition.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Botany (AREA)
  • Agronomy & Crop Science (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

An antimicrobial composition including the aqueous fraction collected following the steam distillation of the foliage of melaleuca plants and a process for preparing the antimicrobial composition including: a) supplying foliage from melaleuca (linerafolia) and/or melaleuca (alternafolia) plants to a sealed vessel; b) passing steam through the foliage in the sealed vessel to extract oil therefrom and collecting the steam thereafter; c) cooling the steam to form an oil phase and an aqueous antimicrobial composition, and d) separating the oil phase from the antimicrobial composition.

Description

ANTIMICROBIAL COMPOSITION
The present invention relates to a process for preparing antimicrobial compositions, to the antimicrobial compositions so prepared and to methods of using the antimicrobial compositions.
BACKGROUND
An antimicrobial composition is a composition which includes natural or artificial agents which prevent the growth of or kill microorganisms.
There are many different types of antimicrobial compositions that are known. Some compositions may only be effective to prevent the growth of or kill a limited number or type of microorganisms. However, there are also other well known antimicrobial composition which can prevent the growth of or kill a wide range of types of microorganisms.
There are also a large range of different processes for preparing antimicrobial compositions. Some of these processes are very complicated and some are very simple.
Applicant has, however, developed a new process for the preparation of an antimicrobial composition.
Applicant has now surprisingly found that a by-product formed during the extraction of oil from the foliage of melaleuca plants is a very effective antimicrobial composition. It has previously been known that tea tree oil (ie oil extracted from melaleuca plants) is effective as an antibactericide. However, the present invention does not relate to this oil. The present invention relates to the composition remaining after the oil component produced from the distillation of melaleuca plants has been extracted. This composition has unexpectedly and surprisingly been found to have a very effective antimicrobial activity at levels far greater than tea tree oil.
SUMMARY
According to one aspect of the present invention there is provided a process for preparing an antimicrobial composition including:
a) supplying foliage from melaleuca (linerafolia) and/or melaleuca (altemafolia) plants to a sealed vessel,
b) passing steam through the foliage in the sealed vessel to extract oil therefrom and collecting the steam thereafter,
c) cooling the steam to form an oil phase and an aqueous antimicrobial composition, and
d) separating the oil phase from the antimicrobial composition.
According to another aspect of the invention there is provided an antimicrobial composition including the aqueous fraction collected following the steam distillation of the foliage of melaleuca plants.
Further according to the invention there is provided a method of treating a viral, fungal or bacterial infection which includes administering an effective amount of the antimicrobial composition of the invention to the site of the infection.
DETAILED DESCRIPTION
The process for preparing the antimicrobial composition may be conducted in any suitable apparatus. In a preferred embodiment the process is conducted in a standard steam distillation apparatus. The quantity of foliage supplied in step a) of the process will depend on the size of the sealed vessel. The sealed vessel may have a 1600 litre capacity. However, vessels up to and above 5 tonne (5000 litres) may be used. If a sealed vessel of 1600 litre capacity is used in the process, then there is usually about 0.2 to 0.5 tonne of foliage supplied to the vessel.
The sealed vessel used in the process of the invention may be of any suitable design and construction such that the foliage can be contained in a steam tight environment. Further, the sealed vessel must be designed such that steam can pass through the foliage.
The steam may be generated within the sealed vessel. Alternatively, the sealed vessel may include a steam inlet and the steam may be supplied to the inside of the vessel from a boiler or steam generator which is connected to the steam inlet. The steam inlet is preferably positioned such that the steam may enter the vessel and pass evenly through all of the foliage supplied thereto. In most cases the steam inlet will be positioned in the base or a lower side wall of the sealed vessel.
The sealed vessel may also include a grid adapted to hold the foliage above the base of the vessel to enable an even flow of steam to pass through the foliage. The optimum position of the grid above the base of the vessel will depend upon the amount of foliage to be steamed and the size of the vessel. For a 1,600 litre vessel the grid is preferably positioned about 200 - 500 mm (usually about 300 mm) above the base of the sealed vessel.
The mesh size of the grid will depend upon the size of the foliage. In a preferred embodiment the foliage is chipped prior to being placed in the vessel to maximise the surface exposure of the foliage to the steam. In one embodiment of the invention the foliage is chipped to sizes of about 50 mm2 to 75mm2 and the mesh size of the grid is 50 mm2. The foliage in the sealed vessel is subjected to steam for any suitable time such that the optimum amount of oil is extracted from the foliage. The time will be dependent on the size of the vessel, the quantity of foliage and the temperature and pressure of the steam. For example, for a 1600 litre capacity sealed vessel holding 0.5 tonne of foliage the foliage is generally steamed for two to three hours at a temperature of 100°C.
After the steam has passed through the foliage and the oil has been extracted therefrom the steam is collected. Preferably the sealed vessel is provided with an outlet in the top or an upper side wall through which the steam may pass and be collected.
Following collection of the steam it is then necessary for the steam to be cooled to form an oil phase and an aqueous antimicrobial composition. This may be achieved by any suitable means, for example it may be achieved by passing the collected steam through a standard condenser.
On cooling of the steam it forms two immiscible phases, an oil phase which forms an upper layer and an aqueous antimicrobial composition which forms a lower layer. The oil phase may be separated from the antimicrobial composition by any suitable means. In a basic system the oil phase is simply skimmed or decanted from the top of the antimicrobial composition. Alternatively the oil phase may be drained from the top of the antimicrobial composition or the antimicrobial composition may be drained from the bottom of the container in which the two immiscible phases were collected.
The antimicrobial composition prepared by the above method has been found to be very effective with killing or preventing the growth of a wide range of microorganisms. For example, the antimicrobial composition has been used in the treatment of viral, bacterial and fungal infections in mammals including both humans and domestic pets. In particular the antimicrobial composition has been found to be effective in the treatment of viral infections such as parvovirus and heφes. It has also been found to be effective in the treatment of fungal infections such as ringworm or tinea. In addition, it has also been found to be effective in the treatment of bacterial infections such as Escherichia coli, Staphylococcus aureus. Leqionella pneumophila and acne.
Any suitable amount of the antimicrobial composition may be used to prevent the growth of or kill microorganisms. The preferred amount of antimicrobial composition to be used will depend on the method of application and the number and type of microorganisms.
In a preferred embodiment of the invention the antimicrobial composition as prepared by the process is directly applied to a microorganism. This may be achieved by directly dabbing the area of infection with enough composition to form a thin layer thereover.
In other embodiments of the invention the antimicrobial composition may be used as a preventive composition by directly applying the composition to a cut or abrasion.
In yet another embodiment of the invention the anitmicrobial composition may be used as a relief composition by directly applying the composition to a painful site, such as an insect bite or sting, sunburn or other burns and as an after body waxing lotion.
Those skilled in the art will appreciate that the antimicrobial composition may have many other uses and that the above examples should be read as only some examples of uses for the composition.
The effectiveness of the antimicrobial composition will now be described with reference to some particular examples. However, it should be understood that the use of the composition is not limited to the treatment of the microorganisms referred to therein.
Example 1
Test Procedure:
The relative efficacy of the antimicrobial composition was compared with a known effective disinfectant, 2.5% gluteraldehyde and a distilled water control.
Materials and Methods
Materials:
Product: Antimicrobial composition prepared by the method of the invention.
Virus: Canine Parvovirus, strain DV I333-4 obtained from Prof. Margaret Sabine, University of Sydney.
Virus Indicator
System: FK continuous cell line/pig red blood cells (PBRC)
Artificial soil: 10 per cent Foetal Bovine Serum (FBS)
Disinfectant Inactivator System: Amrad-Pharmacia Dextran 2000 Blue Chromatography
Method
Product and controls were mixed 50:50 with virus suspension in culture medium containing 10% FBS at room temperature. At 10 and 30 minutes, samples were taken and passed through a column of Dextran 2000 Blue to remove residual disinfectant. Ten-fold dilutions were made and inoculated into FK cells to titrate surviving viruses. After 5 days incubation, virus end-points were determined by the presence/absence of haemagglutination of PRBC. Virus titres were calculated by the method of Reed and Muench and the relative efficacy of the different test preparations determined. A 4 log10 reduction or better is required for a disinfectant claim to be made. This may be reduced to a 3 log10 reduction were the virus indicator/inactivation system does not enable a 4 log10 reduction to be demonstrated.
Results
Virus % kill titre, log10
Water control 6.00
2.5% Gluteraldehude (10 min) <2.40 >99.97
(30 min) <2.40 >99.97
Product (10 min) 5.40 75.00
(30 min) 4.84 93.00
< = less than > ; = greater than
Comments
There was a reduction in the virus titre brought about by the antimicrobial composition. This was a 0.60 log10 (75%) reduction at 10 minutes and a 1.16 log10 (93%) at 30 minutes. To make a disinfectant claim, there should be a 3-4 log10 (99.9 - 99.99%) reduction in 10 minutes. This was observed with the gluteraldehyde positive control.
Example 2
Test organisms: The organisms used in this example were:
Escherichia coli NCTC 8196
Staphylococcus aureus NCTC 4168
MRSA: hospital strain resistant to penicillin, ampicillin, cephalosporin, tetracycline, gentamicin and streptomycin.
Inoculum 8
All innocula were 18 hour cultures with a cell density of approximately 108 cells/mL.
Test Procedure
1. 0.1 mL of each of the test organisms was inoculated into: (i) 9.9mL antimicrobial composition
(ii) 9.9mL 0.1 % peptone water (control).
2. Mixtures were incubated at 37°C throughout the test period.
3. Mixtures were sampled 0, 15, 30 and 60 minutes, in order to enumerate viable organisms. Serial dilutions were prepared in 0.1% peptone water, and 1mL aliquots used to prepare pour plates with Plate Count Agar. Colonies were counted after incubation at 37°C for 48 hours.
Results S. aureus
Cell concentration % kill log
Control 5.8 - Product 15 min 5.2 75 30 min 0.6 99.999 60 min ND* >99.999
MRSA
Cell concentration % kill logio Control 6.5
15 min <4 >99 30 min 1 99.999 60 min ND* >99.999 E. Coli
Cell concentration % logio
Control 6.6
15 min 5.1 97
30 min 3.7 99.9 60 min ND* >99.999
*ND : Not detectable
Comments
Under the test conditions employed, the antimicrobial composition was responsible for a reduction in cell count of each of the three test organisms. At 15 minutes, this was a 75% reduction for S. aureus, a Gram-positive bacterium, >99% for the multi-resistant strain of S. aureus (MRSA) tested and 97% for E. coli, a Gram-positive bacterium. A 5-6 Iog10 reduction was achieved for each of the test organisms after a contact time of 60 minutes with the antimicrobial composition.
Those skilled in the art will appreciate that there may be many variations and modifications of the process and compositions described herein which are within the scope of the present invention.

Claims

CLAIMS:
1. A process for preparing an antimicrobial composition including:
a) supplying foliage from melaleuca (linerafolia) and/or melaleuca (altemafolia) plants to a sealed vessel,
b) passing steam through the foliage in the sealed vessel to extract oil therefrom and collecting the steam thereafter,
c) cooling the steam to form an oil phase and an aqueous antimicrobial composition, and
d) separating the oil phase from the antimicrobial composition.
2. A process according to claim 1 wherein steam is passed through the foliage for two to three hours.
3. A process according to claim 1 or claim 2 wherein steam is passed through the foliage at a minimum temperature of about 100°C.
4. An antimicrobial composition when prepared by the proce<=<- of any one of claims 1 to 3.
5. An antimicrobial composition including the aqueous fraction collected following the steam distillation of the forage of melaleuca plants.
6. A method of treating a microbial infection which includes administering an effective amount of the antimicrobial composition as defined by claim 4 or 5, to the site of the infection.
7. A method of treating a bacterial infection which includes administering an effective amount of the antimicrobial composition as defined by claim 4 or 5, to the site of the infection.
8. A method according to claim 7 wherein the antimicrobial composition is dabbed directly on to the site of infection to form a thin layer thereover.
PCT/AU1997/000092 1996-02-20 1997-02-20 Antimicrobial composition WO1997030718A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU17135/97A AU1713597A (en) 1996-02-20 1997-02-20 Antimicrobial composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPN8156A AUPN815696A0 (en) 1996-02-20 1996-02-20 Anti-microbial composition
AUPN8156 1996-02-20

Publications (1)

Publication Number Publication Date
WO1997030718A1 true WO1997030718A1 (en) 1997-08-28

Family

ID=3792470

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU1997/000092 WO1997030718A1 (en) 1996-02-20 1997-02-20 Antimicrobial composition

Country Status (2)

Country Link
AU (1) AUPN815696A0 (en)
WO (1) WO1997030718A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999038521A1 (en) * 1998-02-02 1999-08-05 Boehringer Ingelheim Vetmedica Gmbh The use of combinations of active agents consisting of antimicrobially active substances and plant extracts containing terpene in veterinary medicine
EP1209238A1 (en) * 2000-06-23 2002-05-29 SAKAI, Takuo Process for producing plant-origin antibacterial substance

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8944391A (en) * 1990-10-22 1992-05-20 Roy J. Mankovitz Topical preparation and method for suppression of skin eruptions caused by herpes simplex virus
WO1993017558A1 (en) * 1992-03-03 1993-09-16 Reginald Keith Whiteley A disinfecting composition
US5385733A (en) * 1990-10-22 1995-01-31 Mankovitz; Roy J. Topical preparation and method for suppression of skin eruptions caused by herpes simplex virus
AU3530495A (en) * 1994-09-27 1996-04-19 Joan Louise Hibberd Treatment of periodontal and acute gingival infections

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8944391A (en) * 1990-10-22 1992-05-20 Roy J. Mankovitz Topical preparation and method for suppression of skin eruptions caused by herpes simplex virus
US5385733A (en) * 1990-10-22 1995-01-31 Mankovitz; Roy J. Topical preparation and method for suppression of skin eruptions caused by herpes simplex virus
WO1993017558A1 (en) * 1992-03-03 1993-09-16 Reginald Keith Whiteley A disinfecting composition
AU3530495A (en) * 1994-09-27 1996-04-19 Joan Louise Hibberd Treatment of periodontal and acute gingival infections

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF APPLIED BACTERIOLOGY, Volume 78, (1995), CARSON C.F. and RILEY T.V., "Antimicrobial Activity of the Major Components of the Essential Oil of Melaleuca Alternifolia", pages 264-269. *
LETTERS IN APPLIED MICROBIOLOGY, Vol. 16, (1993), CARSON C.F. and RILEY T.V., "Antimicrobial Activity of the Essential Oil of Melaleuca Alternifolia", pages 49-55. *
LETTERS IN APPLIED MICROBIOLOGY, Vol. 21, (1995), RAMAN A. et al., "Antimicrobial Effects of Tea-Tree Oil and Its Major Components on Staphylococcus Aureus, Staph. Epidermidis and Propionibacterium Acnes", pages 242-245. *
MEDICAL JOURNAL OF AUSTRALIA, Volume 160, 236, (1994), CARSON C.F. and RILEY T.V., "The Antimicrobial Activity of Tea Tree Oil". *
PATENT ABSTRACTS OF JAPAN, C-942, page 142; & JP,A,04 041 407 (HIROYUKI KOIKE), 12.02.92. *
PATENT ABSTRACTS OF JAPAN, C-970, page 97; & JP,A,04 112 801 (KARUFUA KEMIKARU K.K.), 14.04.92. *
PERFUMER AND FLAVORIST, Vol. 4, (1979), BEYLIER M.F. et al., "Bacteriostatic Activity of Some Australian Essential Oils", pages 23-25. *
PROGRAM AND ABSTRACTS OF THE ANNUAL SCIENTIFIC MEETING OF THE AUSTRALIAN SOCIETY FOR MICROBIOLOGY, PERTH, WESTERN AUSTRALIA, 1993, HAYES A.J. et al., "Relationship Between Chemical Composition and Antimicrobial Activity of Australian Tea Tree Oil", Abstract P2.2, page A-4, Melbourne, Australia: Australian Society *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999038521A1 (en) * 1998-02-02 1999-08-05 Boehringer Ingelheim Vetmedica Gmbh The use of combinations of active agents consisting of antimicrobially active substances and plant extracts containing terpene in veterinary medicine
EP1209238A1 (en) * 2000-06-23 2002-05-29 SAKAI, Takuo Process for producing plant-origin antibacterial substance
EP1209238A4 (en) * 2000-06-23 2002-10-25 Takuo Sakai Process for producing plant-origin antibacterial substance

Also Published As

Publication number Publication date
AUPN815696A0 (en) 1996-03-14

Similar Documents

Publication Publication Date Title
US5425944A (en) Antimicrobial grapefruit extract
Waksman Antagonistic relations of microörganisms
Mundt Occurrence of enterococci: bud, blossom, and soil studies
Menzies et al. Recent advances in cultural management of diseases of greenhouse crops
US11033486B2 (en) Plant composition, preparation method and application thereof
CN110732014B (en) Traditional Chinese medicine composition for removing mites as well as preparation method and application thereof
CN109221296A (en) A kind of plant degerming bio-fermented liquid and preparation method thereof
CN106234388B (en) A kind of composition pesticide of alkene containing benzo fluorine bacterium azoles and jamaicin
US5783604A (en) Germicidal compositions containing iodine compounds
CN107737290A (en) A kind of Chinese medicine composition, pharmaceutical preparation and its application
CN116210728B (en) Bactericide and preparation method and application thereof
WO1997030718A1 (en) Antimicrobial composition
CN109674702B (en) Clove compound natural preservative, preparation method and application in cosmetics
CN109362801A (en) A kind of nanometer of animal and veterinary thimerosal and preparation method thereof
CN108812707A (en) One kind killing thrips plant essential oil composition, preparation and its application
Easwaramoorthy et al. The effect of subnormal concentrations of insecticides in combination with the fungal pathogen, Cephalosporium lecanii Zimm. in the control of coffee green scale, Coccus viridis Green
CN101632392A (en) Application of bryophyte as disinfectant for plant explants, disinfectant composition as well as preparation method and use method thereof
CN112516237A (en) Sterilization and deodorization spray for pets and preparation method thereof
JPH0616514A (en) Sporicide
JPH0625045B2 (en) Herbicides and weeding methods for weed grasses
US4584198A (en) Therapeutic compositions having antibacteric activity comprising a fraction extracted from camomile flowers and process for the preparation of said fraction
Linfield A comparative study of the effects of five chemicals on the survival of chlamydospores of Fusarium oxysporum f. sp. narcissi
Kleinhempel et al. Disinfection of pruning shears for the prevention of the fire blight transmission
CN110720459A (en) Aspergillus flavus prevention and treatment composition containing perillaldehyde and calcium ion chelating agent EDTA and application thereof
KR20210014043A (en) 10% benzalkonium chloride disinfectant and disinfectant composition containing clove oil

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN YU AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 97529660

Format of ref document f/p: F

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase